Renal outcomes with the newer antidiabetes drugs: the era before and after CREDENCE
Rajani A, Sahay M, Bhattacharyya A, Amar A
Diabet Med. Pub. online 3 February 2020
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Sex differences in metabolic regulation and diabetes susceptibility
Tramunt B, Smati S, Grandgeorge N, et al.
Diabetologia. 2020;63:453-61
Leggi
Preterm birth and risk of type 1 and type 2 diabetes: a national cohort study
Crump C, Sundquist J, Sundquist K
Diabetologia. 2020;63:508-18
Leggi
Effects of once-weekly semaglutide vs once-daily canagliflozin on body composition in type 2 diabetes: a substudy of the SUSTAIN 8 randomised controlled clinical trial
McCrimmon RJ, Catarig AM, Frias JP, et al.
Diabetologia. 2020, 63:473–485
Leggi
The effect of dulaglutide on stroke: an exploratory analysis of the REWIND trial
Gerstein HC, Hart R, Colhoun HM, et al.
Lancet Diabetes Endocrinol. 2020;8(2):106-14
Leggi
Smoking cessation and weight change in relation to cardiovascular disease incidence and mortality in people with type 2 diabetes: a population-based cohort study
Liu G, Hu Y, Zong G, et al.
Lancet Diabetes Endocrinol. 2020;8(2):125-33
Leggi
Diabetes: a metabolic and reproductive disorder in women
Thong EP, Codner E, Laven JSE, Teede H
Lancet Diabetes Endocrinol. 2020;8(2):134-49
Leggi
Healthy lifestyle and life expectancy free of cancer, cardiovascular disease, and type 2 diabetes: prospective cohort study
Li Y, Schoufour J, Wang DD, et al.
BMJ. 2020;368 :l6669
Leggi
Distinct Metabolic Profile in Early Pregnancy of Overweight and Obese Women Developing Gestational Diabetes
Mokkala K, Vahlberg T , Pellonperä O, et al.
J Nutr. 2020;150(1):31-7
Leggi